Building Global Life Sciences Patent Portfolios: Strategy, Structure, and Execution

Building Global Life Sciences Patent Portfolios: Strategy, Structure, and Execution

View Session Speakers

Life sciences patent portfolios are built under extreme constraints: long development timelines, regulatory uncertainty, jurisdictional complexity, and relentless cost pressure. Decisions made early—often before clinical proof—can determine whether a portfolio supports exclusivity, partnering, and valuation, or collapses under validity challenges and global enforcement friction.

This panel examines how to build global life sciences patent portfolios with strategic intent and operational discipline. Panelists will discuss how to align portfolio structure with therapeutic strategy, development milestones, and commercial objectives, while managing jurisdictional trade-offs and budget realities. The discussion will address claiming approaches for products, platforms, methods, and manufacturing, as well as the coordination of patents with regulatory exclusivities.

The conversation will also explore execution challenges, including global filing strategy, prosecution harmonization, continuation practice, and portfolio pruning as programs advance or fail. Panelists will examine how portfolio design affects licensing, enforcement, M&A, and investor perception across different markets.

Survey

https://www.surveymonkey.com/r/Building-Global-Life-Sciences-Patent-Portfolios